WANG Lie's Experience in Treating Combined Allergic Rhinitis and Asthma Syndrome in Children by Stages with the Principle of “Treating Lung and Nose Simultaneously”
GAO Fa,LI Jing.WANG Lie's Experience in Treating Combined Allergic Rhinitis and Asthma Syndrome in Children by Stages with the Principle of “Treating Lung and Nose Simultaneously”[J].Journal of Traditional Chinese Medicine,2023,64(15):1525-1529.
GAO Fa,LI Jing.WANG Lie's Experience in Treating Combined Allergic Rhinitis and Asthma Syndrome in Children by Stages with the Principle of “Treating Lung and Nose Simultaneously”[J].Journal of Traditional Chinese Medicine,2023,64(15):1525-1529.DOI: 10.13288/j.11-2166/r.2023.15.003.
This paper summarized the clinical experience of Professor WANG Lie in treating combined allergic rhinitis and asthma syndrome (CARAS) in children by stages from the perspective of “treating lung and nose simultaneously”. It is proposed to treat CARAS as “nasal asthma” from attack period, remission period and stable period. In attack period, the key pathogenesis is wind-cold stirring the lungs and internal heat accumulating in the spleen, for which the treatment is to dispel cold and clear heat, unblock the nose and relieve asthma, and modified
Bixiao Decoction
(鼻哮汤) is usually used. In the remission period, the key pathogenesis is healthy
qi
deficiency and pathology not leaving, phlegm-rheum lingering, and the treatment is to regulate the lung and resolve phlegm, tonify the kidney and fortify the spleen, usually using modified
Xiaotan Decoction
(哮痰汤). In the stable period, the key pathogenesis is healthy
qi
deficiency and insecurity, latent phlegm accumulation in the lung, for which it is suggested to boost
qi
and suppress phlegm, consolidate the root and prevent asthma with modified
Guxiao Formula
(固哮方). In clinical practice, the approved formulas are used in their modifications according to the symptoms, and good curative effect has been achieved.
关键词
Keywords
references
TOGIAS A . Rhinitis and asthma:evidence for respiratory system integration [J]. J Allergy Clin Immunol , 2003 , 111 ( 6 ): 1171 - 1183 .
CHERVINSKY P , NAYAK A , ROOKLIN A , et al . Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis [J]. Allergy Asthma Proc , 2005 , 26 ( 5 ): 391 - 396 .
PAIVA-FERREIRA LKD , LAMPAIVA-FERREIRA , MONTEIRO TM , et al . Combined allergic rhinitis and asthma syndrome (CARAS) [J]. Int Immunopharmacol , 2019 , 74 : 105718 . doi: 10.1016/j.intimp.2019.105718 http://dx.doi.org/10.1016/j.intimp.2019.105718 .